| Device |
anti-human globulin |
| Regulation Description |
Anti-Human Globulin. |
| Definition |
For the performance of direct and indirect antiglobulin tests in blood banking/ immunohematology |
| Physical State |
Sourced from either serum from animals immunized with one or more human serum globulins or from stable immunoglobulin secreting cell lines |
| Technical Method |
Antigen and Antibody Reaction by hemagglutination, Column Agglutination (gel technique), solid phase or microplate |
| Target Area |
Red blood cells, serum, plasma |
| Regulation Medical Specialty |
Hematology |
| Review Panel |
Hematology |
| Product Code | QHS |
| Premarket Review |
Center for Biologics Evaluation & Research (CBER)
|
|
Unclassified Reason
|
Pre-Amendment
|
| Submission Type |
Contact ODE
|
| Regulation Number |
660.50
|
| Device Class |
Unclassified
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |